Leonora started work as a pharmacist practicing in hospital psychiatric pharmacy and community-based opiate dependence pharmacotherapy dispensing.
Her PhD at Monash University, completed in 2006, built on these interests, investigating cannabis-based compounds in rodent behavioural models of schizophrenia symptoms.
Following a postdoctoral position at the University of Sydney she returned to investigating cannabinoids in a genetic animal model of schizophrenia with Schizophrenia Research Institute and Neuroscience Research Australia. She is a recipient of a Rafaelsen Young Investigator Award and an Ian Potter Foundation Travel Award and presently, she is appointed as a postdoctoral Research Officer in the Schizophrenia Research Laboratory.
Her research aims are to investigate the role of endogenous cannabinoids in regulating brain development and to assess the impact of disruption of this regulation, in conjunction with other environmental and genetic risk factors, on adolescent and adult mental health.
In the last year, she has published three papers in high profile journals such as Psychopharmacology and the International Journal of Neuropsychopharmacology.
Click here to access Dr Leonora Long's research papers:
